Skip to main content

Volaris Group Acquires Surveypal Oy

TORONTO, July 14, 2025 (GLOBE NEWSWIRE) — Volaris Group today announced the acquisition of Surveypal Oy, a Finnish company that provides automated survey software to measure company data using the Software-as-a-Service model. Surveypal Oy’s tools deliver business intelligence metrics to ~600 companies in the Finnish market and internationally. “We are excited to welcome Surveypal Oy’s talented and dedicated team to Volaris Group,” says Janni Løber Zesach, Group Leader, Volaris Group. “The acquisition of Surveypal Oy expands our network of expertise in the Nordic region – growing the community of leaders that Volaris is forever invested in.” Founded in 2007, Surveypal Oy was created to elevate feedback management solutions and has two primary offerings. Survey Tool that allows users to easily create surveys and export...

Continue reading

Global Crossing Airlines Completes First Aircraft Acquisition and Adds Four More to Support Continued Business Growth

MIAMI, July 14, 2025 (GLOBE NEWSWIRE) — Global Crossing Airlines Group, Inc. (Cboe CA: JET, Cboe CA: JET.B, OTCQB: JETMF) (“GlobalX” or the “Company”), the Nation’s fastest-growing charter airline, today announced the completion of its first aircraft acquisition, along with the signing of lease agreements for four additional Airbus aircraft—significant steps in supporting the Company’s continued business expansion. GlobalX has acquired an Airbus A320 (MSN 3101), currently operating in its fleet as N630VA and powered by two CFM56-5B engines. The aircraft was purchased from Falcon 2019-1 Aerospace Limited by an affiliate of GlobalX, with financing provided by Volofin Capital Management Ltd. of London. “This acquisition marks a major milestone for GlobalX as we transition from an exclusively leased fleet to a hybrid ownership model,”...

Continue reading

180 Degree Capital Corp. Notes Filing of Definitive Materials for Proposed Business Combination with Mount Logan Capital and Will Host a Shareholder Call on Tuesday, July 15, 2025, at 1 PM ET

The Special Meeting of Shareholders to approve the Business Combination with Mount Logan Capital to be Held on August 22, 2025, with a record date for the meeting of July 8, 2025 MONTCLAIR, N.J., July 14, 2025 (GLOBE NEWSWIRE) — 180 Degree Capital Corp. (NASDAQ:TURN) (“180 Degree Capital”) today noted the filing of the definitive proxy materials for its proposed merger with Mount Logan Capital Inc. (“Mount Logan”) in an all-stock transaction (the “Business Combination”) after the market closed on Friday, July 11, 2025. The Board of Directors of 180 Degree Capital (the “Board”) has set the date of the Special Meeting for the approval of the Business Combination (the “Business Combination Special Meeting”) as August 22, 2025. The Board has set the record date for the Business Combination Special Meeting as July 8, 2025. The mailing...

Continue reading

Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions

Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons’ needs Acquisition expected to be neutral to adjusted earnings per share in 2025 – 2027 and accretive thereafter and to contribute to revenue growth beginning in 2027 WARSAW, Indiana and AUSTIN, Texas, July 14, 2025 (GLOBE NEWSWIRE) — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Monogram Technologies Inc. (NASDAQ: MGRM), an orthopedic robotics company, today announced they have entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of stock of Monogram for an upfront payment of $4.04 per share in cash, corresponding to an equity value of approximately $177 million and an enterprise value of approximately $168 million....

Continue reading

Form 8.3 – [ALPHA GROUP INTERNATIONAL PLC – 11 07 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ALPHA GROUP INTERNATIONAL PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

MAAS Announces Signing of Acquisition Framework Agreement

CHENGDU, China, July 11, 2025 (GLOBE NEWSWIRE) — Maase Inc. (NASDAQ: MAAS) (“MAAS” or the “Company”) today announced that it has signed a non-binding framework agreement with certain shareholders of Qingdao Youdian New Energy Technology Co., Ltd. (“Youdian”) and Qingdao Huijulaixi Intelligent Technology Co., Ltd. (“LaiXi”) to acquire 100% equity of Youdian and 49% equity of LaiXi. The transaction is expected to close in the third quarter of 2025, marking a pivotal step in MAAS’s strategic expansion into new energy technology and intelligent service sectors. Youdian is an innovative technology company focusing on the new energy sector, with two primary business areas: electric vehicle (EV) services and residential energy solutions. With strong research and development capabilities and an end-to-end service...

Continue reading

Shareholders of Renergen Limited Approve Proposed Acquisition by ASP Isotopes Inc.

WASHINGTON, July 11, 2025 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that at a general meeting of shareholders of Renergen Limited (“Renergen”) held on July 10, 2025, Renergen shareholders voted overwhelmingly in favor of the acquisition of Renergen by ASP Isotopes through a scheme of arrangement (the “Scheme”) in accordance with Sections 114 and 115 of the South African Companies Act, No. 71 of 2008. The Scheme received support from 99.80% of voting shareholders. The implementation of the Scheme remains subject to and will only become operative upon the fulfilment or, if applicable, waiver of a number of conditions,...

Continue reading

NV5 Acquires Professional Systems Engineering; Strengthens Technology Design for Public Safety Facilities

HOLLYWOOD, Fla., July 11, 2025 (GLOBE NEWSWIRE) — NV5, a provider of tech-enabled engineering, certification, and consulting solutions, announced today its acquisition of Professional Systems Engineering, LLC, (PSE) a leading designer of facility technologies for corrections and public safety infrastructure throughout the Northeast. Founded in 1986, PSE’s engineers and consultants specialize in the design of security, safety, fire, and communication systems for high-security public sector facilities such as corrections, justice, healthcare, and educational facilities. “NV5 is a leader in the design of audiovisual, fire protection, security, surveillance, and intelligent building systems that employ the latest technologies to improve the safety, function, and comfort of the built environment,” said Ben Heraud, CEO of NV5. “Professional...

Continue reading

Ikena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Merger with Inmagene Biopharmaceuticals

BOSTON, July 11, 2025 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,” the “Company”) today announced that Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”) recommend that stockholders vote FOR the issuance of shares in connection with the previously disclosed proposed merger with Inmagene Biopharmaceuticals (“Inmagene”) at Ikena’s upcoming Annual Meeting of Stockholders on July 15, 2025. ISS and Glass Lewis are leading U.S. institutional voting advisory services that regularly publish analyses on public shareholder votes. Inmagene is a privately held, clinical stage biopharmaceutical company focused on developing IMG-007, a nondepleting anti-OX40 monoclonal antibody (mAb) engineered to have a silenced antibody-dependent cellular cytotoxicity (ADCC) function to minimize potential...

Continue reading

Helix Acquisition Corp. II and BridgeBio Oncology Therapeutics Announce Effectiveness of Registration Statement for Proposed Business Combination

Extraordinary General Meeting of Helix Shareholders Scheduled for August 4, 2025 SOUTH SAN FRANCISCO & BOSTON, July 11, 2025 (GLOBE NEWSWIRE) — Helix Acquisition Corp. II (“Helix”) (Nasdaq: HLXB), a special purpose acquisition company (“SPAC”) sponsored by Cormorant Asset Management, and TheRas, Inc. (d/b/a BridgeBio Oncology Therapeutics) (“BBOT”), a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies, today announced that the registration statement on Form S-4 (File No. 333-288222) (as amended, the “Registration Statement”), filed by Helix and BBOT, relating to the previously-announced business combination among Helix, BBOT, and the other parties thereto (the “Business Combination”), has been declared effective by the U.S....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.